‘Not Much We Can Do’: Vaccine Makers Lash Out at RFK Jr. as Sales Slide
Drug industry executives are lashing out as U.S. Health Secretary Robert F. Kennedy Jr. tightens vaccine standards, re-examines childhood schedules and demands what he calls gold-standard science. “I’m seriously frustrated,” Pfizer’s CEO said of Kennedy’s changes, which are cutting U.S. vaccine sales and slowing new trials.
Asked what would need to change to move vaccine discussions forward, Pfizer CEO Albert Bourla answered: “The secretary of health,” The Wall Street Journal reported Wednesday. Bourla has emerged as Kennedy’s most vocal critic, calling his approach “anti-science.”
“I’m seriously frustrated,” “What is happening has zero scientific merit and is just serving an agenda which is political and antivax.”
Sanofi CEO: ‘Very little’ to do but wait for elections